University of Colorado Cancer Center
Playback speed
10 seconds
Venetoclax Combinations in AML: Addition of Aza/Dec in Previously Untreated Patients, Improvemens & Expansions, Predicting Non-responders
By
University of Colorado Cancer Center
FEATURING
Daniel Pollyea
By
University of Colorado Cancer Center
FEATURING
Daniel Pollyea
66 views
May 27, 2021
Login to view comments.
Click here to Login
Oncology Grand Rounds